Unleash Immuno Oncolytics, Inc.

CIK 1732374 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Unleash Immuno Oncolytics, Inc..

Recent SEC filings

FiledFormAccession number
Jul 28, 2026SCHEDULE 13G0001493152-26-035076
Feb 22, 2018D0001732374-18-000001